Anavex Life Sciences Corp is a biopharmaceutical company that focuses on developing drug candidates for the treatment of central nervous system diseases. They have several drug candidates currently in different clinical trials for a variety of conditions including Alzheimer's disease, Rett syndrome, Parkinson's disease, epilepsy, multiple sclerosis, and cancer. The company was founded in 2004 and has its headquarters in New York.